EZH2 and colorectal carcinoma: Epigenetic control of autophagy by methyltransferases has been reported in the setting of colorectal carcinoma where the methyltransferase EZH2 inhibits several negative regulators of mTOR (mechanistic target of rapamycin [serine/threonine]) leading to inhibition of autophagy [38].